# Intravenous Iron Sucrose for Acute Decompensated Heart Failure Patients With Reduced Ejection Fraction and Iron Deficiency

> **NCT06703411** · PHASE4 · COMPLETED · sponsor: **Cheng-Hsin General Hospital** · enrollment: 76 (actual)

## Conditions studied

- Heart Failure With Reduced Ejection Fraction (HFrEF)
- Hospitalization
- Iron Deficiency

## Interventions

- **DRUG:** Iron Sucrose IV
- **DRUG:** Standard Medical Therapy

## Key facts

- **NCT ID:** NCT06703411
- **Lead sponsor:** Cheng-Hsin General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-01
- **Primary completion:** 2024-10-31
- **Final completion:** 2024-10-31
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2024-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06703411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06703411, "Intravenous Iron Sucrose for Acute Decompensated Heart Failure Patients With Reduced Ejection Fraction and Iron Deficiency". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06703411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*